Literature DB >> 13766949

The design of sensitivity tests on tubercle bacilli.

J MARKS.   

Abstract

Keywords:  ANTITUBERCULAR AGENTS/pharmacology; MYCOBACTERIUM TUBERCULOSIS/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13766949     DOI： 10.1016/s0041-3879(61)80114-1

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  5 in total

1.  Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Malcolm D Yates; Francis A Drobniewski
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  Low incidence of rifampicin-resistant tubercle bacilli.

Authors:  C H Collins; M D Yates
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

3.  First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

4.  Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.

Authors:  J Banks; P A Jenkins
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

5.  Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.